The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IBC 2025 | Developing mouse models to identify therapy-resistant cells in follicular lymphoma
Dinis Calado, PhD, The Francis Crick Institute, London, UK, briefly discusses the value of using mouse models to identify therapy-resistant follicular lymphoma cells, sharing insights into some of his ongoing research in the lab. This interview took place at the 3rd Intercepting Blood Cancers (IBC) Workshop held in Nice, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
